Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Community First Bancshares Inc (CFBI)

Community First Bancshares Inc (CFBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,314
  • Shares Outstanding, K 7,571
  • Annual Sales, $ 16,640 K
  • Annual Income, $ 360 K
  • 60-Month Beta 0.62
  • Price/Sales 2.69
  • Price/Cash Flow 61.44
  • Price/Book 0.96
Trade CFBI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.22
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/11/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.50 +6.11%
on 12/21/20
10.18 -0.98%
on 01/20/21
+0.62 (+6.55%)
since 12/18/20
3-Month
7.10 +41.97%
on 11/02/20
10.18 -0.98%
on 01/20/21
+2.78 (+38.12%)
since 10/20/20
52-Week
5.36 +88.06%
on 04/02/20
12.00 -16.00%
on 01/21/20
-1.93 (-16.07%)
since 01/17/20

Most Recent Stories

More News
Can-Fite CEO Dr. Pnina Fishman to be Guest Speaker at 5th Annual NASH Summit 2021

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite’s Piclidenoson Commences Clinical Study for the Treatment of Canine Osteoarthritis

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite to Present at H.C. Wainwright 7th Annual Israel Conference

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite’s Findings on Cannabis Compound’s Inhibition of Liver Cancer are Published in HEPATOLOGY and will be Presented at the AASLD’s The Liver Meeting® 2021 Conference

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite’s NASH Patents Granted and Allowed in Japan, Hong Kong, and Mexico

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite CEO to Present Namodenoson’s Clinical Trial Data as Expert Speaker at 5th Annual Antifibrotic Drug Development Summit

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite CEO to Join Benzinga Medical Cannabis Panel and Deliver Company Presentation at Healthcare Small Cap Conference on September 29, 2021

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)
Can-Fite to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...

CANF : 1.2279 (+0.65%)
CFBI : 10.08 (-0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Community First Bancshares, Inc. is a bank holding company. It offer financial products and services which includes savings accounts, personal and business loans, debit and credit cards, letter of credit, certificate of deposits, mortgages, equipment financing, cash management and online banking. Community...

See More

Key Turning Points

3rd Resistance Point 10.34
2nd Resistance Point 10.26
1st Resistance Point 10.17
Last Price 10.08
1st Support Level 10.00
2nd Support Level 9.92
3rd Support Level 9.83

See More

52-Week High 12.00
Last Price 10.08
Fibonacci 61.8% 9.46
Fibonacci 50% 8.68
Fibonacci 38.2% 7.90
52-Week Low 5.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar